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ABSTRACT  Studies using genetic and  biochemical  probes  have suggested  that mouse  sperm 
surface galactosyltransferases  may participate during fertilization by binding  N-acetylglucosa- 
mine (GIcNAc) residues in the egg zona pellucida. In light of these results, we examined sperm 
surface galactosyltransferase  activity during in vitro capacitation to determine whether changes 
in enzymatic activity correlated with fertilizing ability. Results show that surface galactosyltrans- 
ferases on  uncapacitated  sperm  are  preferentially  loaded  with polyN-acetyllactosamine  sub- 
strates. As a consequence of capacitation in Ca+÷-containing medium, these polylactosaminyl 
substrates  are  spontaneously  released  from  the  sperm  surface,  thereby exposing the  sperm 
galactosyltransferase  for binding to the zona pellucida.  Sperm capacitation can be mimicked, 
in the absence of Ca ++, either by washing sperm in Ca++-free  medium, or by pretreating sperm 
with antiserum  that reacts with the galactosyltransferase  substrate.  In  both  instances,  sperm 
galactosylation  of  endogenous  polylactosaminyl  substrates  is  reduced,  coincident  with  in- 
creased  galactosylation  of exogenous GIcNAc,  and  increased  binding to the zona  pellucida. 
Binding of capacitated sperm  to the egg can be inhibited by pronase-digested high molecular 
weight polylactosaminyl glycosides  extracted from  epididymal fluids or from  undifferentiated 
F9  embryonal  carcinoma  cells.  Thus,  these  glycosides  function  as  "decapacitation  factors" 
when  added  back  to  in  vitro  fertilization  assays. These glycoside  "decapacitation  factors" 
inhibit sperm-egg  binding by competing for the sperm  surface  galactosyltransferase,  since  (a) 
they are galactosylated  by sperm  in  the  presence  of  UDP[3H]galactose,  and  (b)  enzymatic 
removal  of  terminal  GIcNAc  residues  reduces  "decapacitation  factor"  competition.  On  the 
other hand, "conventional"  low molecular weight glycosides,  isolated from either epididymal 
fluid or differentiated F9 cells, fail to inhibit capacitated sperm  binding to the zona pellucida. 
These results  define  a molecular  mechanism  for one aspect  of sperm  capacitation, and  help 
explain why removal  of "decapacitation factors" is a necessary  ~rerequisite for sperm  binding 
to the zona pellucida. 
This  paper  addresses  the  molecular  basis  of one  particular 
aspect of mouse sperm capacitation. Before mammalian sperm 
are capable of binding to the egg zona pellucida or completing 
the acrosome reaction, they must be capacitated. According to 
present knowledge, sperm capacitation is a multifaceted process 
involving changes in sperm surface glycoconjugates, antigens, 
lipids,  intramembrane particles, fluidity, ion permeability, and 
sperm  intermediary  metabolism  (see  references  4  and  5  for 
review). One of the first events occurring during capacitation 
is the release of an epididymal fluid glycoconjugate from the 
sperm surface, which can inhibit capacitated sperm binding to 
the zona pellucida  when added back to in vitro fertilization 
assays.  These  "coating"  or  "decapacitation  factors"  can  be 
released by either elevated ionic strength (6), or by glycosidase 
digestion,  such as fl-N-acetylhexosaminidase (7).  These,  and 
other results,  suggest that epididymal glycoconjugates are ab- 
sorbed to the sperm surface and are released coincident with 
capacitation.  After  the  release  of sperm  surface  glycosides, 
capacitation  results  in  an  increase  in  sperm  respiration,  in 
sperm forward motility, and enables the sperm to complete the 
acrosome reaction (4, 5, 8). There is much species variation in 
the timing of the acrosome reaction, but in mouse, it is thought 
that  only acrosome-intact sperm  are  capable  of binding  the 
zona pellucida (9).  After zona binding, the acrosome releases 
hydrolytic enzymes that allow the sperm to penetrate the egg 
investments. 
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penetration of the zona peUucida. Much research is directed at 
identifying  the receptor on sperm surfaces that mediates rec- 
ognition of the zona peUucida.  A  lectinlike  protein has been 
isolated from sea urchin sperm (10), which may participate in 
fertilization  by  binding  vitelline  layer  glycoconjugates  (11). 
Recent  work  on  mouse  sperm  suggests  that  sperm  surface 
galactosyltransferases  may participate  during  fertilization  by 
binding GIcNAc residues in the zona pellucida (1-3,  12). This 
conclusion  is  supported  by  several  genetic and  biochemical 
observations. For example, mutant t-sperm that have a genetic 
predisposition  for increased  fertilizing  ability have a  specific 
fourfold increase in surface  GlcNAc:galactosyltransferase  ac- 
tivity, while eight other t-sperm enzyme activities are indistin- 
guishable  from  normal.  Sperm  beating  recombinant  t-chro- 
mosomes,  which  do  not  affect  fertilization,  have  galactosyl- 
transferase  activity  equal  to  normal  (1,  2).  In  addition,  the 
presence of either a galactosyltransferase inhibitor, or a specific 
galactosyltransferase modifier protein, inhibits both sper~a sur- 
face  galactosyltransferase  activity  and  sperm  binding  to  the 
zona pellucida,  but does not inhibit a variety of other sperm 
enzymes (3). 
As part of our analysis of sperm surface galactosyltransfer- 
ases during mouse fertilization, we examined whether in vitro 
capacitation  had  any  effect  on  surface  galactosyltransferase 
activity. We focused our attention on the requisite release of 
epididymal  glycoconjugates  that  occurs  during  capacitation, 
since  we thought  this  could  have  dramatic  consequences  on 
sperm  surface  galactosyltransferase  activity.  Specifically,  we 
wanted to know whether mouse sperm capacitation  involved 
the release of galactosyltransferase  substrates from the sperm 
surface, thereby exposing the enzyme for binding to the zona 
peUucida.  Additionally,  we  examined  whether  the  released 
galactosyl acceptors could serve as competitive "decapacitation 
factors" when added back to in vitro fertilization assays. This 
paper reports experiments aimed at testing these possibilities. 
The accompanying paper (3) presents our biochemical evidence 
for  sperm  surface  galactosyltransferase  binding  to  the  zona 
pellucida. 
MATERIALS AND  METHODS 
Gametes 
Viable cauda epididymal sperm were collected from either CDI  (Charles 
River) or inbred normal-tail BTBRTF/Nev males, filtered through 35/~m mesh 
nylon cloth, washed by centrifugation and prepared for galactosyltransferase 
assay as previously described (1).  Epididymal fluid contamination of the final 
sperm pellet was diluted by over 1.25 ×  106-fold (1).  Eggs were isolated from 
superovulated CDI  females in a modified complete medium (CM) (13)  minus 
lactose, plus 5.6 mM fructose. The eggs were freed from the surrounding cumulus 
ceils with 0.1% hyaluronidase (Sigma Chemical Co., St.  Louis, MO) (23°C,  10 
rain), then washed three times in CM and used for in vitro sperm binding assays 
as described below. 
In Vitro Fertilization Assays 
Viable sperm were removed from minced cauda epididymides and capacitated 
in CM for 1 h in a 37°C, 7% CO2 tissue-culture incubator. The sperm concentra- 
tion  and  motility were  determined with a  hemocytometer.  40-/~1 aliquots of 
capacitated sperm were added to ~30 cumulus-free eggs in 400/~1 of CM, under 
mineral oil. Within any one set of assays, on a given day, control and experimental 
incubations were prepared from a common sperm suspension. In this way, sperm 
concentration and motility were identical in all cultures, thus eliminating inevi- 
table variations between males sacrificed on different days. Sperm binding to the 
zona pelhicida, as assayed below, was proportional to the final sperm concentra- 
tion from  1-5 ×  sperm/ml. Assays usually contained 3  ×  105 sperm/ml final 
concentration, of which >50% were motile. 
In our initial experiments the cultures were incubated in a reciprocating (30 
reciprocations/rain) 37°C water bath, while in our more recent assays the cultures 
were incubated in a stationary 37°C, 7% CO2 tissue-culture incubator. Results 
were qualitatively the same under both incubation conditions. After 20 min of 
incubation, the entire 440-~1 suspension was applied to the top of a discontinuous 
microgradient composed of 50 #1 of CM,  25/tl of 1.8% dextran, and 25 Ill of 
2.25% dextran containing 2.5% glutaraldehyde (14). The gradient was centrifuged 
for 90 s at 100 g, sedimenting the eggs with adhering sperm into the glutaralde- 
hyde-containing dextran  layer.  Unbound  sperm  partitioned  in  the  CM  and 
adjacent 1.8% dextran layers. The egg pellets were removed and the number of 
sperm bound/egg was counted using phase-contrast microscopy. The number of 
eggs examined for each data point is given in the appropriate table. 
Galactosyltransferase Assay 
Sperm galactosyltransferase  activity  was assayed as previously described under 
optimal enzymatic conditions, in which enzyme activity is linear for at least 3 h 
(1,  2).  Incubations  contained  0.5  ×  106  sperm,  203  /~M  UDP[3H]galactose 
(UDPGal) (197 mCi/mmol) (New England Nuclear, Boston, MA), and 10 mM 
MnCI~ in 50 ~tt of Medium B (NaCI, 7.5 g/l; KC1, 0.4 g/l; HEPES buffer, 4.76 g/ 
1; pH 7.2). When assaying for exogenous acceptor activity, 30 mM GlcNAc was 
also  added.  After  the  indicated  incubation  times  at  37°C,  the  assays  were 
terminated with l0/,d Na EDTA, pH 7.2, of which 50 #l was subjected to high- 
voltage borate  electrophoresis (3,000  volts, 280  mA, 42  rain) to separate the 
reaction products from unused UDPGal and UDPGal degradation products (1, 
2).  An  incubated  assays  have  had  background  levels of radioactivity (0°C 
incubations) subtracted from them. 
In some assays, heat-inactivated (60°C, 30 min) aliquots of the epididymal 
supernatant were added to extensively  washed sperm, so that soluble epididymal 
acceptors could be glycosylated by sperm galactosyltransferases. 
Galactosyl Product  Characterization 
To characterize the galactosyltransferase reaction products, the standard in- 
cubation mixture was scaled up sixfold in volume and incubated for 2 h at 37°C. 
One set of assays was extracted with chloroform:methanol (2:1 ) (15) to determine 
the presence of galactosylated glycolipids. Another set of assays was detergent- 
extracted with 30 mM n-octylglucoside (Sigma Chemical Co.) for  1 h  on ice. 
After extensive trituration, the detergent extract was centrifuged to remove the 
ceils (1,200  g,  10 rain,  10°C),  and  the  supernatant was extensively dialyzed 
against  Medium  B  to  remove  detergent  and  unused  sugar nucleotide.  The 
resulting preparation was heat-inactivated (60  ° C, 30 rain) to destroy any endog- 
enous enzyme activity. 
Dialyzed,  detergent-extracted,  galactosylated products  were  digested  with 
either 10 mg/ml pronase (Calbiochem-Behrmg Corp., San Diego, CA) with 10 
mM CaCl2, or 15 mU endo-fl-galactosidase (keratanase purified from Pseudom- 
onas) (16),  (Miles Laboratories Inc., Elkhart, IN) for 48 h at 37°C, after which 
additional pronase (10 mg/ml) or keratanase (15 mU) was added to the appro- 
priate tubes and incubated for an additional 48 h. The resulting material was 
chromatographed on Sephadex G-50 (Pharmacia Fine Chemicals, Piscataway, 
N J)  as  described  below.  Endo-fl-galactosidase reportedly  had  no  detectable 
protease, a-fucosidase, a- and fl-galactosidase, a- and fl-glucosidase, a- and fl-N- 
acetylgalactosaminidase, a- and ~-N-aeetylghicosaminidase, a- and/3-mannosi- 
dase, fl-mamaosaminidase, fl-xylosidase, sulfatase, hyaluronidase, nor chondro- 
itinase contamination. All enzyme units are defined as  1 U  liberating 1 /~mol 
reducing sugar/min. 
Column Chromatography 
Undigested, pronase-digested, and endo-fl-galactosidase-digested  labeled gly- 
coconjugates were applied to Sephadex G-50 (free) columns (1.8  ×  60 cm) and 
eluted with 0.05 M acetic acid, adjusted to pH 6.0 with NH4OH. Eighty 2.0-ml 
fractions were collected, with a flow rate of 30 ml/h, and the radioactivity  in each 
was determined using ACS (Amersham Corp., Arlington Heights, IL) aqueous 
scintillant. Generally,  blue  dextran  eluted  at  fractions 23-31,  glycopeptides 
prepared from parietal endoderm (2,000-3,500 mol wt) at 41-50, and UDPGal 
at 57-63. 
Im  m  u noprecipita tion 
Syngeneic anti-F9 antiserum recognizes a family of complex poly N-acetyllac- 
tosamine glycoconjugates  on embryonal carcinoma (EC) cells, sperm and embry- 
onic ceils (17-19).  Anti-F9 antiserum and  129/SV normal mouse serum were 
prepared as previously described (17),  such that antiserum reacted specifically 
with EC ceils, and not with lymphocytes nor with yolk sac endoderm. 200/~1 of 
the dialyzed, detergent-extracted, galactosylated material was incubated with 
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FRACTION  NUMBER 
FIGURE  1  Sephadex  G-S0 elution  profiles of  detergent-extracted 
galactosyltransferase  reaction products. (A)  Pronase-digested  gly- 
copeptides from fresh epididymal sperm suspensions. (B) Pronase- 
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anti-F9 antiserum or normal mouse serum (1/60 final dilution) for 1/2 h at 37°C, 
followed by  1/2 h  at 4°C.  100 #1 of goat lgG antimouse IgG, IgM, and IgA 
heavy and light chain antiserum (Cappel Laboratories, Cochranville, PA) were 
then added, and the tubes were incubated for another hour at 37°C, and then 
overnight at 4°C. The pellets were collected by centrifugation, washed twice with 
Medium B, and dissolved with 200 #1 1 N NaOH. This immunoprecipitation was 
repeated  three  times  for  each  aliquot of galactosylated glycoconjugate, the 
dissolved precipitates were pooled, 2 ml H20 were added, and the precipitates 
were counted using ACS aqueous scintillant. 
Enzymatic Digestion of Intact Sperm 
Suspensions of epididymal sperm were centrifuged and resuspended in 0.1 ml 
of Medium B, to which were added 60 #1 of the protease inhibitor, Aprotinin 
(Sigma Chemical Co.),  and either 15 mU endo-fl-galactosidase, I U fl-N-acetyl- 
glucosaminidase, or  an equivalent volume (90 gl) of Medium B.  The  sperm 
suspensions were incubated for 90 min with gentle agitation at 37°C, after which 
they were washed with 10 ml of Medium B and resuspended for galactosyltrans- 
ferase assay. 
Detergent Extraction of F9 and Retinoic Acid- 
treated F9 Cells 
Cell surface glycoeonjugates were extracted from F9 EC and retinoic acid- 
treated EC cells as previously described (19).  Pronase-digested F9 cell extracts 
are highly enriched for poly N-acetyUactosamme glycosides, while retinoic acid- 
treated ceUs do not synthesize these glycoconjugates. 
RESULTS  AND  DISCUSSION 
Olycoprotein:galactosyltransferases  normally  transfer  galac- 
tose  from UDPGal to terminal  GIcNAc residues,  or to free 
GIcNAc, to produce N-acetyllactosaminyl linkages  (i.e.,  Gal 
GlcNAc)  (20).  Results  below  show  that  glycoprotein:ga- 
lactosyltransferases on the surface of uncapacitated sperm are 
loaded with polylactosaminyl substrates (i.e., GIcNAc ~  (Gal 
GIcNAC)n).  By assaying galactosyltransferase  activity to- 
wards  both  endogenous  and  exogenous  (i.e.,  GlcNAc) sub- 
strates, we could show that endogenous polylactosaminyl gal- 
actosyltransferase substrates  are spontaneously released from 
the sperm surface during in vitro capacitation.  Furthermore, 
intentional removal of surface galactosyltransferase substrates 
mimics capacitation.  These released substrates  serve as deca- 
pacitation factors by binding back to the sperm surface, and 
thus inhibit sperm binding to the zona pellucida. 
Characterization  of the Sperm Surface 
Galactosyltransferase Substrates as 
Polylactosaminyl  Glycosides 
In our first experiments, a freshly isolated cauda epididymal 
sperm suspension, essentially free of somatic cells, was assayed 
for galactosyltransferase  activity towards endogenous accep- 
tors. Previous studies have shown that the galactosyltransferase 
assay  conditions  were  optimal  for  UDPGal,  GlcNAc,  and 
MnC12 concentrations,  proportional  to sperm  concentration, 
and linear with incubation time (1). The reaction products were 
isolated  and  pronase-digested  (see  Materials  and  Methods), 
and  the  resultant  glycopeptides  were  chromatographed  on 
Sephadex G-50 to determine their relative sizes. Fig. 1  A shows 
digested glycopeptides from heat-inactivated epididymat fluids ga- 
lactosylated by washed sperm. (C) 48-h endo-fl-ga[actosidase  diges- 
tion of galactosylated  products used in  B. (D) 96-h endo-fl-galac- 
tosidase digestion of galactosylated products used in  B. Galactosyl- 
transferase assays,  enzymatic digestion and column chromatography 
were conducted as described in  Materials and Methods.  Vo:  void 
volume.  Vi: included volume. 
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sylated.  This  elution  profile  was  not  affected  by  continued 
incubation with additional pronase. 
We wanted  to determine  whether either  of the galactosyl- 
transferase substrates in the epididymal fluid was glycosylated 
by sperm surface galactosyltransferases. To do this, the sperm 
were removed by centrifugation, and the epididymal superna- 
tant was heat-inactivated to destroy soluble galactosyltransfer- 
ase. Mild heat-inactivation did not affect the endogenous high 
and low molecular weight (tool wt) glycoside substrates, since 
they could be galactosylated by unheated epididymal suspen- 
sions. The sperm pellet was extensively washed by centrifuga- 
tion, resulting in a  1.25 x  10~-fold dilution of epididymal fluid 
contamination. The final sperm pellet showed negligible levels 
of endogenous  substrates,  but retained high levels of activity 
toward exogenous GIcNAc, in agreement with previous studies 
(1, 3). The heat-inactivated epididymal supernatant was added 
back  to  extensively  washed  sperm  and  assayed  for  sperm 
galactosyltransferase  activity  towards  epididymal  acceptors. 
The resulting pronase-digested galactosylated products eluted 
from  Sephadex  G-50  as  seen  in  Fig.  I b.  Only  the  larger 
glycopeptide,  eluting  near  the  void  volume,  was  obtained. 
Thus,  sperm  specifically galactosylated  the  larger  molecular 
weight glycopeptide, while the smaller molecular weight gly- 
copeptide was a substrate specific for soluble, epididymal fluid 
galactosyltransferases. These results show that the cauda epi- 
didymal sperm suspension contained at least two distinct gal- 
actosyltransferase activities, only one of which was specifically 
associated  with  the  sperm  surface.  Therefore,  the  following 
studies used heat-inactivated epididymal fluid supernatants as 
an acceptor source for sperm surface galactosyltransferases. 
The large molecular weight galactosyl acceptors glycosylated 
by sperm surface galactosyltransferases were partially charac- 
terized as follows. First,  the reaction products were extracted 
with chloroform:methanol to determine the presence of glyco- 
lipid  substrates.  Only  8% of the  total products  were  chloro- 
form:methanol  soluble  (279  cpm  out  of  3,474  cpm  total). 
Second, sperm surface galactosyltransferase reaction products 
were digested with purified endo-fi-galactosidase (keratanase) 
to  determine  whether  lactosaminyl  residues  (i.e.,  Gal 
GIcNAc)  were  present.  As  shown  in  Fig.  1 c,  63%  of  the 
galactosyl acceptors were degraded  into smaller oligosaccha- 
rides  after  2  d  of digestion,  as  assessed  by  Sephadex  G-50 
chromatography.  Endo-fl-galactosidase  digestion  for 4  d  de- 
graded over 90% of the galactosylated products (Fig.  1 d). The 
intermediate-sized oligosaccharides seen in Fig. 1 c were chased 
into  low  molecular  weight  di-  and  trisaccharides  (Fig.  I d), 
demonstrating  the  polylactosaminyl  nature  of the  reaction 
products. 
Further  insight  into the nature  of the large mol wt sperm 
surface galactosyl acceptors was obtained  by specific immu- 
noprecipitation  with  anti-F9  antiserum.  Antiserum  raised 
against  syngeneic  F9  embryonal  carcinoma  (EC)  ceils,  and 
absorbed with  syngeneic lymphocytes and  differentiated  EC 
cells, recognizes a class of poly-N-acetyllactosamine glycocon- 
jugates on F9 ceils and embryonic ceils (17-19,  2l).  Anti-F9 
antiserum  also  reacts  with  sperm  (22),  so  we  determined 
whether the sperm surface galactosyltransferase acceptor sub- 
strates were  also recognized by syngeneic anti-F9  antiserum. 
Anti-F9 antiserum immunoprecipitated 87% (1,043 cpm)of the 
galactosylated product(s), while under identical conditions (see 
Materials  and  Methods),  normal  mouse  serum  precipitated 
only 9.2% (110 cpm) of the product. 
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Competition between  Endogenous 
Polylactosaminyl Substrates and Exogenous 
GIcNAc for the Sperm 
Surface Galactosyltransferase 
To assess the  level of galactosyltransferase activity during 
capacitation,  it  was  necessary  to  establish  that  exogenous 
(GlcNAc) and endogenous (polylactosaminyl) substrates were 
being galactosylated by the same enzyme. Therefore, the fol- 
lowing experiments assayed for competition between endoge- 
nous and exogenous substrates for the sperm surface galacto- 
syltransferase. Epididymat sperm suspensions were pretreated 
with  either  endo-fl-galactosidase,  to create terminal  GIcNAc 
residues, or buffer, washed once by centrifugation, and assayed 
for galactosylation of either endogenous glycosides or exoge- 
nous GlcNAc. Fig. 2 shows that endo-B-galactosidase pretreat- 
ment elevated activity towards  endogenous  substrates  to the 
same  degree  that  it  inhibited  galactosylation  of exogenous 
GlcNAc. On the other hand, fl-N-acetylglucosaminidase pre- 
treatment, which cleaved terminal GIcNAc residues, produced 
the reciprocal effect, inhibiting endogenous galactosylation by 
50% while simultaneously stimulating galactosylation of exog- 
enous GlcNAc nearly twofold (Fig. 3). Therefore, by selectively 
exposing or removing endogenous GIcNAc residues on poly- 
lactosaminyl acceptors, galactosylation of exogenous GlcNAc 
was either inhibited (Fig. 2) or stimulated (Fig. 3), respectively, 
showing the competitive nature of the endogenous polylacto- 
saminyl acceptors and exogenous GlcNAc. 
We examined whether anti-F9 antiserum could also be used 
to demonstrate  competition between endogenous  and  exoge- 
nous substrates, since we knew that anti-F9 antiserum bound 
the  endogenous  galactosyltransferase  substrate  (see  above). 
This was found to be the case, since the presence of anti-F9 
antiserum  inhibited  glycosylation  of  endogenous  acceptors 
while stimulating galactosylation of exogenous GIcNAc. Nor- 
mal mouse serum had no significant effect on either endoge- 
nous or exogenous acceptor glycosylation (Table I). Galacto- 
syltransferases endogenous  to the  sera were  heat-inactivated 
before the experiment. For these assays, the sperm suspension 
was washed once by centrifugation to remove soluble enzyme 
activity,  while  maintaining  moderate  levels  of endogenous 
acceptors. 
To assess the  specificity of the anti-F9  antiserum,  another 
UDPGal-requiring  enzyme, nucleotide  pyrophosphatase, was 
examined.  After  90  min  of  incubation  without  antiserum, 
UDPGal accounted for 88.1% of the total soluble radioactivity; 
Gal-phosphate,  10.2%; and Gal,  1.7%. In the presence of anti- 
F9 antiserum, UDPGal hydrolysis was indistinguishable from 
controls;  UDPGal  87.4%;  Gal-phosphate,  10.8%; and  Gal, 
1.8%. These results are similar to previous studies, which have 
also shown that, under identical conditions, anti-F9 antiserum 
had no effect on sperm surface sialyltransferase, alkaline phos- 
phatase or acid phosphatase activities (1). 
Reduced Levels of Endogenous Polylactosaminyl 
Substrates Correlate with Sperm Capacitation 
In Vitro 
Fresh epididymal sperm are uncapacitated  in that they are 
relatively unable to bind or penetrate the zona pellucida. The 
followin  8  experiments examined  whether sperm capacitation in vitro is associated with removal of competing polylactosa- 
minyl substrates from the sperm surface galactosyltransferase. 
Sperm capacitation was functionally assayed by determining 
the number of sperm bound to the zona pellucida as described 
in Materials and Methods. 
Other workers have  shown  that  in vitro mouse  sperm ca- 
pacitation (i.e., increased sperm binding to the zona) is Ca  ++- 
e¢ 
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FIGURE  2  Sperm surface galactosyltransferase activity towards en- 
dogenous, cell-bound  acceptors after either endo-18-galactosidase 
(0-  -@)  or  buffer  (H)  pretreatment.  The effect of  endo-,8- 
galactosidase ((3- -O) or buffer ((3  O) pretreatment on galacto- 
syltransferase activity  towards  exogenous GIcNAc  is  also  shown. 
Sperm  preparation, enzymatic digestion, and galactosyltransferase 















i  I 
iii 
1~~ I~  - 
;  3'0  6;  9; 
TI M E  (min) 
Sperm surface galactosyltransferase activity towards en- 
dogenous, cell-bound acceptors after either `8-N-acetylglucosamin- 
idase (O- -0) or buffer (H)  pretreatment. The effect of ,8- N- 
acetylglucosaminidase (O- -O) or buffer (©  O) pretreatment on 
galactosyltransferase activity  towards  exogenous GIcNAc  is  also 
shown.  Sperm  preparation,  enzymatic  digestion,  and  galactosyl- 
transferase assay were as in Materials and Methods. 
TABLE  I 
Removal of Competitive Sperm Surface Polylactosaminyl  Glycosides during Capacitation 
Experi- 
ment  Sperm treatment 
Control 
Normal mouse serum  (1/60 final dilution) 
Anti-F9 antiserum (1/60 final dilution) 
Control (Ca++-free CM) 
2.0 mM Ca  ++ 
Control (unwashed) 
Washed, resuspended in original supernatant 
Washed, resuspended in fresh Ca++-free CM 
Number 
of eggs  Sperm bound/egg  pmol product/106 sperm, 90 min 
Gal --, endogenous  Gal --~ GIcNAc 
20  2.4  8.9 +  0.6  17.2 --+ 0.3 
26  2.2  8.1 +  0.7  15.5 +  0.2 
31  5.0 (P <  0.01)  3.0 +  0.1  32.3 +-- 0.3 
76  10.1  9.6 +-- 0.3  10.3 +  0.5 
59  29.2  (P <  0.005)  4.9 +  0.5  17.2 +  0.5 
25  9.1  46.1 +_ 1.4  nd. 
22  8.6  n.d.  n.d. 
27  22.3  (P <  0.005)  6.6 +  0.6  n.d. 
Aliquots of sperm were assayed  for capacitation and surface galactosyltransferase activities towards endogenous and exogenous (i.e., GIcNAc) substrates. Within 
any one experiment,  sperm were taken from a common  suspension to insure equal motility and concentration,  thus avoiding  inevitable variations  between 
different sperm suspensions. Sperm capacitation  was assessed  by measuring the number of sperm bound/egg in the absence of Ca  ++ , except in Ex. 2.90-rain 
galactosyltransferase  activities represent the average of four, 120-rain time courses, ±SEM. Galactosyltransferase assays  contained 10 mM MnCl2, except those in 
which  the effect of Ca  ++ was examined (Ex. 2) thus producing  lower endogenous activity compared to Ex. 3. Endogenous activity is low in Ex. 1, compared to Ex. 
3, due to mild centrifugal  washing  (as in Figs. 2 and 3). Activity  towards endogenous substrates has been subtracted from activity  towards GIcNAc n.d., not 
determined. 
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was examined in vitro after preincubating epididymal sperm 
in Ca++-containing or Ca++-free medium for 1 h. As seen in 
Table I, sperm capacitation was accentuated by preincubation 
in 2.0 mM Ca  ++, since binding to the zona increased by 2.9- 
fold.  Simultaneously,  2.0 mM  Ca  ++ pretreatment  stimulated 
sperm  glycosylation of exogenous  GIcNAc by  1.7-fold  and 
concomitantly inhibited glycosylation of  endogenous substrates 
by 0.5, all relative to sperm incubated in the absence of Ca  ++  . 
The addition of 4 mM EDTA eliminated virtually all sperm 
binding to the zona pellucida (<1.0 sperm bound/egg). 
We examined whether sperm capacitation could be mim- 
icked, in the absence of Ca  ++, by simply centrifugally washing 
away the sperm surface endogenous galactosyl acceptors. Re- 
suits  show  (Table  I) that  washing uncapacitated  sperm  and 
resuspending them in fresh Ca++-free CM mimicked capaci- 
tation,  since there  was  a  2.5-fold increase  in  binding  to the 
zona pellucida.  Sperm motility was identical in both washed 
and unwashed preparations so long as CM was present. Parallel 
galactosyltransferase  assays  showed  a  concomitant  86%  de- 
crease in endogenous acceptor galactosylation. 
In the absence of Ca  ++, anti-F9 antiserum pretreatment also 
mimicked  sperm  capacitation  since  sperm-zona  binding  in- 
creased 2.1 times as a result of anti-F9 antiserum pretreatment 
(Table  I).  Under  identical  conditions,  normal  mouse  serum 
had no effect. Similarly, the results described above show that 
anti-F9  antiserum,  but  not  normal  mouse  serum,  inhibited 
sperm galactosylation of endogenous acceptors while stimulat- 
ing activity towards exogeneous acceptors. Again, no motility 
differences  could  be  detected,  and  no  antiserum-mediated 
sperm agglutination could be found. 
Released Polylactosaminyl  Glycosides  Serve as 
Competitive  Decapacitation  Factors 
To determine whether either size class of epididymal fluid 
glycosides (see Fig. 1A ) could decapacitate sperm (i.e., inhibit 
capacitated  sperm binding to the zona pellucida),  we added 
both  size  classes  of epididymal  glycosides back  to  in  vitro 
fertilization assays. Epididymal glycosides were prepared from 
CDI males as follows. Fresh epididymal sperm was pelleted 
by centrifugation  and  the  resulting supernatant  was exhaus- 
tively pronase-digested,  boiled  to denature  the pronase,  and 
chromatographed on Sephadex G-50 with 0.05 M ammonium 
bicarbonate, pH 7.7. The void volume containing the polylac- 
tosaminyl  glycosides  (Fig.  I A)  was  lyophilized  and  resus- 
pended in BSA-free CM. Similarly, the included volume con- 
taining the low mol wt epididymal fluid galactosyltransferase 
substrates was lyophilized and resuspended. Results show that 
epididymal  polylactosaminyl glycosides,  which  serve  as  the 
preferential  substrate  for uncapacitated  sperm surface galac- 
tosyltransferases, inhibited binding by 63% relative to controls 
(Table  II).  In  three  separate  experiments,  polylactosaminyl 
glycoside inhibition of sperm binding was proportional to the 
amount of glycoside added, i.e.,  ~ycoside extracted from 1.2 
x  l0 7 SpelTn produced 39% inhibition, extract from 2.2  ×  10  7 
TABLE  II 
Effect of Polylactosaminyl Glycoconjugates on Sperm Binding to the Zona Pellucida 
Glycoside source  Assay additions  Eggs  Sperm bound/egg 
Fpididymal fluids  Medium (control)  29  16.8 
Polylactosaminyl glycosides  35  6.2 (P < 0.005) 
Low tool wt "conventional" glycosides  29  15.3 
F9 Cells (embryonal carcinoma)  Medium (control)  52  26.3 
Polylactosaminyl glycosides  54  2.5 (P < 0.005) 
Retinoic acid-treated F9 cells (endo-  Medium (control)  20  41.2 
derm)  "Conventional" glycosides  23  43.6 
Epididymal fluids were pronase-digested, boiled, and chromatographed on Sephadex G-50. The void volume (polylactosaminyl glycosides) and included volume 
(low tool wt glycosides) were lyophilized and added to sperm zona binding assays. F9 cell polylactosaminyl glycoconjugates and retinoic acid-treated cell surface 
glycoconiugates were added to sperm-zona binding assays at equal concentrations, when normalized to the number of cells extracted (1.2 x  10  s cells equivalents/ 
440 gl assay). See reference 19 for details of F9 cell glycoconjugate extraction and characterization. 
Go I  /  / 
GIcNAc  GIcNAc 
/  Go,  y 
GoI  / 
Gol-transferase  /  GIcNAc 
CAPACITATION 
UGIcNACGol  {  ~'~ 
cNAc  GIcNAc 
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FIGURE 4  Diagram illustrating the release 
of  poly- N-acetyllactosamine  glycosides 
from  the sperm surface  during capacita- 
tion. Glycoconiugate release could be fa- 
cilitated by either dilution in the oviduct, 
increased ionic strength, gtycosidase diges- 
tion or UDPGal-mediated catalysis of the 
galactosyltransferase  reaction.  In  this fig- 
ure, only the terminal disaccharides of the 
"decapacitation  factors"  are  illustrated. 
(Figure adapted from reference 12). sperm gave 63% inhibition, extract from 2.9 x  107 sperm gave 
94% inhibition. On the other hand, the low mol wt glycosides, 
which are substrates for soluble galactosyltransferases,  did not 
inhibit binding significantly in any experiment (Table II). 
To assess  further  the  specificity  of polylactosaminyl  deca- 
pacitation activity, we examined the decapacitation activity of 
polylactosaminyl glycosides extracted from F9 embryonal car- 
cinema (EC) ceils relative to "conventional" low mol wt gly- 
cosides extracted from differentiated  F9 cells (19). F9 polylac- 
tosaminyl  glycosides  are  similar,  if  not  identical,  to  sperm 
polylactosaminyl glycosides,  since both glycoconjugates show 
similar precipitation with anti-F9 antiserum,  similar suscepti- 
bility  to  endo-fl-galactosidase  digestion,  and  similar  elution 
from Sephadex G-50 after pronase-digestion.  In addition, the 
use of F9 glycosides allowed us to examine whether decapaci- 
tating  polylactosamines  are  substrates  for  sperm surface  ga- 
lactosyltransferases. 
When  F9  cell  poly-N-acetyllactosamine  glycoconjugates 
were  added  back  to  in  vitro  fertilization  assays  containing 
capacitated sperm, binding to the zona was inhibited by up to 
91% (Table  II),  similar to that seen with epididymal poly-N- 
acetyUactosamines.  Exhaustive pronase-digestion  and boiling 
of the polylactosaminyl glycoconjugate did not affect its inhib- 
itory  activity.  Equivalent  concentrations  of  heated  extracts 
from  retinoic-acid-treated  F9  ceils,  which  do  not  synthesize 
these polylactosaminyl glycosides (19), did not inhibit sperm- 
zona binding, thus demonstrating the specific inhibitory nature 
of the  polylactosaminyl  glycoconjugate.  The  solubilized,  de- 
capacitating  glycoconjugates  competed for the sperm surface 
galactosyltransferase, since 6.2 pmol were galactosylated by 106 
sperm in the presence of UDP[3H]Gal, and they simultaneously 
inhibited sperm galactosylation of exogenous GlcNAc by 5.1 
pmol (Table III).  In addition, enzymatic removal of terminal 
GlcNAc  residues  by fl-N-acetylglucosaminidase  reduced  the 
decapacitation  factor activity of the  competitive  polylactosa- 
minyl  glycoside  (no  additions:  31.8  _  3.1  sperm/egg,  undi- 
gested glycoside: 3.2 _+ 0.6 sperm/egg, enzyme digested glyco- 
side:  15.4  __.  3.1  sperm/egg,  all  differences  P  <  0.01).  These 
results  suggest  that  solubilized  polylactosamines  inhibited 
sperm  binding  to  the  zona  pellucida  by  competing  for  the 
surface galactosyltransferase.  However, we do not know what 
effects,  if  any,  polylactosamines  may  have  on  other  events 
during capacitation. 
In summary, the results presented  in this paper show that 
surface  galactosyltransferases  on  uncapacitated  sperm,  are 
TABLE  III 
Glycosylation  of Polylactosaminyl  Glycoconjugates  by Sperm 
Surface Galactosyltransferases 
pmol  prod- 
uct/10  n 
sperm, 90 
Acceptor  Additions  min  Control 
% 
Endogenous  Buffer  3.1  :I: 0.2  100 
Polylactosaminyl  9.3 _+ 0.4  302 
glycosides 
GIcNAc  Buffer  12.4 4- 0.2  100 
Polylactosaminyl  7.3 __. 0.2  59 
glycosides 
Sperm were prepared and assayed for surface  galactosyltransferase  activity as 
described in Materials and Methods. Activity towards endogenous acceptors 
has been subtracted  from  activity towards exogenous GIcNAc.  F9 cell  poly- 
lactosaminyl glycoconjugates were extracted as described 09), and 3.0 x  10  s 
F9 cell  equivalents were added to each 50/~1 assay. Data are the average of 
quadruplicate determinations, ±SEM. 
loaded with high mol wt polylactosaminyl substrates (Fig. 4). 
Sperm  capacitation  in vitro  involves the  requisite  release  of 
these  polylactosaminyl  substrates  from  the  surface,  thereby 
exposing  the  galactosyltransferase.  Furthermore,  these  sub- 
strates serve as "decapacitation factors"  when added back to in 
vitro fertilization  assays,  and  do so  by  binding  back  to  the 
sperm surface galactosyltransferase.  These results are interest- 
ing in light of evidence implicating the sperm surface galacto- 
syltransferase as at least one of the sperm receptors for binding 
to the zona pellucida (see accompanying paper, and 12, 23, 24). 
Therefore,  one result of capacitation  may be the exposure of 
previously  cryptic  sperm  receptors  due  to  the  spontaneous 
release of competitive substrates. 
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